|
BIOSENSE WEBSTER INC OCTARAY MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
|
Back to Search Results |
|
| Catalog Number |
D160905 |
| Medical Device Problem Code |
Obstruction of Flow (2423)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/01/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
E 1.Initial reporter phone : (b)(6) if additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: pc-(b)(6).
|
| |
|
Event or Problem Description
|
|
It was reported that a patient underwent a ventricular tachycardia (vt) ischemic cardiac ablation procedure which included an octaray mapping catheter and the physician noted that the catheter did not irrigate adequately.The catheter was replaced.There was no patient consequence.Additional information was received and it indicated that the issue was discovered while the device was inside the patient.As such, this event was assessed as mdr reportable with an awareness date of 19-feb-2024.
|
| |
|
Additional Manufacturer Narrative
|
|
It was reported that a patient underwent a ventricular tachycardia (vt) ischemic cardiac ablation procedure which included an octaray mapping catheter and the physician noted that the catheter did not irrigate adequately.The catheter was replaced.There was no patient consequence.Additional information was received, and it indicated that the issue was discovered while the device was inside the patient.As such, this event was assessed as mdr reportable with an awareness date of (b)(6) 2024.Device evaluation details: the device was returned to biosense webster (bwi) for evaluation.Visual inspection and irrigation test of the returned device were performed following bwi procedures.Visual analysis of the returned sample revealed no damage nor anomalies on the device.Irrigation testing was performed, and no issues were observed.A manufacturing record evaluation was performed for the finished device number lot 31121942l, and no internal action related to the complaint was found during the review.Additionally, the manufacture and expiration dates have been provided.Therefore, fields d4.Expiration date and h4.Device manufacture date have been populated.The irrigation issue reported by the customer could not be replicated during the product investigation.Other issues or circumstances may have occurred during the usage of the device that compromised its performance.The instructions for use contain the following: prior to inserting the catheter into the body, flush the catheter with heparinized normal saline.Always follow standard practices of using a continuous drip of anticoagulant fluid under pressure, through the irrigation luer, when the catheter is in the body.A rate of 2 ml/min is recommended.If the catheter is removed from the body, flush the catheter before reinserting it.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|